BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
©The Author(s) 2025.
World J Cardiol. Sep 26, 2025; 17(9): 110061
Published online Sep 26, 2025. doi: 10.4330/wjc.v17.i9.110061
Table 1 Characteristics of the selected studies
Ref.
Study design
Population characteristics
Sample size
Intervention (CCTA)
Comparator (stress testing)
Outcomes measured
Key findings
Follow-up duration
Singh et al[11]Post hoc of RCTAdults aged 18-75 with suspected stable angina; Scotland clinics3283CCTA as add-on to standard careExercise ECGCHD death, nonfatal MI, diagnostic accuracyCCTA more predictive of CHD death/MI (HR 10.63); ECG: 39% sensitivity, 91% specificity5 years
Stillman et al[12]Multicenter RCTStable angina, intermediate risk; 44 sites1050CCTA to guide therapy/revascularizationSPECT MPIMACE (MI, cardiac death), revascularizationSimilar outcomes (HR 1.03); CCTA better predicted MACE; fewer events in CCTA-negative patientsMean 16.2 months
Lubbers et al[13]Multicenter RCTStable angina; Dutch outpatient clinics350Tiered: CAC → CCTAFunctional (ECG, MPI, echo)Event-free survival, symptoms, downstream testing, costHigher survival (96.7% vs 89.8%, P = 0.011); less downstream testing; lower cost1.2 years
Lubbers et al[14]Multicenter RCTStable angina; mean pretest CAD probability 54%268Tiered: CAC → CCTA → CT perfusion (if needed)Functional (mostly exercise ECG)Angiograms w/ and w/o revascularization, further testing, efficiencyFewer unnecessary angiograms (1.5% vs 7.2%, P = 0.035); more revascularizations (88% vs 50%, P = 0.017)6 months
Linde et al[15]RCTAcute chest pain with normal ECG/troponin600CCTA-guided; functional added if neededStandard: Bicycle ECG or MPIComposite: Death, MI, UAP, revascularization, readmissionFollow-up


Write to the Help Desk